Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 754

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 754
---
 for its U.S. government agency obligations that were in unrealized loss position as of September 30, 2024. The Company classifies its marketable debt securities based on their contractual maturity dates. As of September 30, 2024, the Company’s marketable debt security matures in November 2024. The amortized cost and fair values of marketable debt securities by contractual maturity were as follows:

| ​                    | ​ | ​ | As of September 30, 2024 |   |       |   |   |   |            |   |       |   | ​ | ​ | As of December 31, 2023 |   |        |   |   |   |            |   |        |   | ​ |
|:---------------------|:--|:--|:-------------------------|:--|------:|:--|:--|:--|:-----------|:--|------:|:--|:--|:--|:------------------------|:--|-------:|:--|:--|:--|:-----------|:--|-------:|:--|:--|
| Contractual maturity | ​ | ​ | AmortizedCost            |   |       |   | ​ | ​ | Fair Value |   |       |   | ​ | ​ | AmortizedCost           |   |        |   | ​ | ​ | Fair Value |   |        |   | ​ |
| Less than one year   | ​ | ​ | ​                        | $ | 5,000 | ​ | ​ | ​ | ​          | $ | 4,975 | ​ | ​ | ​ | ​                       | $ | 49,243 | ​ | ​ | ​ | ​          | $ | 48,983 | ​ | ​ |
| More than one year   | ​ | ​ | ​                        | ​ |     — | ​ | ​ | ​ | ​          | ​ |     — | ​ | ​ | ​ | ​                       | ​ |      — | ​ | ​ | ​ | ​          | ​ |      — | ​ | ​ |
| Total                | ​ | ​ | ​                        | $ | 5,000 | ​ | ​ | ​ | ​          | $ | 4,975 | ​ | ​ | ​ | ​                       | $ | 49,243 | ​ | ​ | ​ | ​          | $ | 48,983 | ​ | ​ |

All available-for